Publications by authors named "Tomoka Usami"

Claim this Profile
C
Current management of hereditary cancer syndromes in ovarian and endometrial cancer: a Japanese study.
Takanori Yokoyama, Yasuko Yamamoto, Mika Okazawa-Sakai, Natsumi Yamashita, Tomoka Usami

Jpn J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trial.
Shin Nishio, Tadaaki Nishikawa, Masahiko Mori, Shoji Kamiura, Toshiyuki Sumi, Tomoka Usami

J Gynecol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study.
Tamaki Tanaka, Kazuhiro Takehara, Tomoka Usami, Masako Ishikawa, Eiji Kondo

Gynecol Oncol Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Domenica Lorusso, Yang Xiang, Kosei Hasegawa, Giovanni Scambia, Manuel Leiva, Tomoka Usami

Lancet· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer.
Kosei Hasegawa, Shunji Takahashi, Kimio Ushijima, Masao Okadome, Kan Yonemori, Tomoka Usami

Cancer Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
Domenica Lorusso, Yang Xiang, Kosei Hasegawa, Giovanni Scambia, Manuel Leiva, Tomoka Usami

Lancet· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer.
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijima, Tomoka Usami

J Gynecol Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826.
Shin Nishio, Kan Yonemori, Tomoka Usami, Shinichiro Minobe, Mayu Yunokawa

Cancer Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE-775.
Kan Yonemori, Mayu Yunokawa, Kimio Ushijima, Jun Sakata, Ayumi Shikama, Tomoka Usami

Cancer Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079).
Terumi Tanigawa, Nobuhiro Takeshima, Hideki Ishikawa, Shin Nishio, Tomoka Usami

Gynecol Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082).
Akiko Furusawa, Munetaka Takekuma, Keita Mori, Tomoka Usami, Eiji Kondo

Int J Gynecol Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of pregnancy outcomes between women with early-onset and late-onset gestational diabetes in a retrospective multi-institutional study in Japan.
Tomoka Usami, Maki Yokoyama, Megumi Ueno, Noriyuki Iwama, Norimasa Sagawa

J Diabetes Investig· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of laparoscopic training for gynecological malignancies using Thiel-embalmed human cadavers.
Tomoka Usami, Toru Fujioka, Ayaka Yoshida, Hitomi Miyaue, Toshiaki Yasuoka

Mol Clin Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of Treatment and Prognosis of Stage IVB Cervical Carcinoma.
Tomoka Usami, Akimasa Takahashi, Maki Matoda, Sanshiro Okamoto, Eiji Kondo

Int J Gynecol Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Huge polypoid endometriosis: report of a case and review of the literature.
Akiko Yamamoto, Tomoka Usami, Eiji Kondo, Kazuyoshi Kato, Teiichi Motoyama

Int Cancer Conf J· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vulvar Reconstruction Following Surgery for Vulvar Cancer Using a Stepladder V-Y Advancement Medial Thigh Flap.
Hidetaka Nomura, Takuma Maeda, Tomoka Usami, Akiko Abe, Akiko Yamamoto

Int J Gynecol Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary debulking surgery for isolated para-aortic nodal recurrence in ovarian cancer involving the division of the left renal vein.
Kazuyoshi Kato, Tomoka Usami, Nobuhiro Takeshima

Gynecol Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Kotaro Sueoka, Kenji Umayahara, Akiko Abe, Tomoka Usami, Akiko Yamamoto

Int J Gynecol Cancer· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring the impact of a national HPV vaccination program in Japan (MINT Study): rationale, design and methods.
Koji Matsumoto, Nobuo Yaegashi, Takashi Iwata, Kazuya Ariyoshi, Kiyoshi Fujiwara, Tomoka Usami

Jpn J Clin Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrence patterns of advanced ovarian, fallopian tube, and peritoneal cancers after complete cytoreduction during interval debulking surgery.
Tomoka Usami, Kazuyoshi Kato, Tomoko Taniguchi, Akiko Abe, Hidetaka Nomura

Int J Gynecol Cancer· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Complications of surgery for gynecologic cancer].
Kuniko Utsugi, Tomoka Usami, Nobuhiro Takeshima, Ken Takizawa

Nihon Rinsho· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis